HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emanuela Mazzon Selected Research

Septic Shock (Toxic Shock Syndrome)

7/2011Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice.
6/2011PPARĪ± mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure.
5/2011Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
2/2010Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.
2/2010PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
8/2007Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence.
10/2006Green tea polyphenol extract attenuates zymosan-induced non-septic shock in mice.
9/2005Melatonin limits lung injury in bleomycin treated mice.
4/2005Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin.
11/2002Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emanuela Mazzon Research Topics

Disease

147Inflammation (Inflammations)
06/2023 - 01/2002
56Spinal Cord Injuries (Spinal Cord Injury)
12/2022 - 02/2005
32Ischemia
12/2014 - 08/2002
31Edema (Dropsy)
01/2019 - 05/2002
31Necrosis
01/2016 - 01/2002
31Shock
06/2012 - 03/2002
29Myelitis
04/2012 - 02/2005
28Lung Injury
03/2024 - 01/2002
28Reperfusion Injury
01/2024 - 01/2002
28Colitis
08/2011 - 05/2002
26Multiple Sclerosis
02/2024 - 08/2013
26Pleurisy (Pleuritis)
01/2024 - 01/2002
26Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 11/2014
25Body Weight (Weight, Body)
05/2012 - 10/2002
22Wounds and Injuries (Trauma)
09/2023 - 07/2002
19Pancreatitis
03/2024 - 05/2002
19Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2011 - 05/2002
18Neoplasms (Cancer)
10/2021 - 06/2004
16Multiple Organ Failure (MODS)
02/2024 - 10/2002
15Alzheimer Disease (Alzheimer's Disease)
04/2023 - 12/2016
15Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 08/2013
15Pneumonia (Pneumonitis)
10/2011 - 03/2004
14Arthritis (Polyarthritis)
01/2024 - 10/2002
13Parkinson Disease (Parkinson's Disease)
11/2023 - 01/2012
12Neuroinflammatory Diseases
04/2023 - 01/2011
10Periodontitis
08/2017 - 06/2005
10Diarrhea
10/2015 - 05/2002
10Experimental Arthritis
12/2011 - 01/2002
10Septic Shock (Toxic Shock Syndrome)
07/2011 - 11/2002
9Neuroblastoma
04/2023 - 07/2017
9Hypoxia (Hypoxemia)
05/2020 - 12/2004
9Hemorrhage
05/2012 - 05/2002
9Weight Loss (Weight Reduction)
02/2009 - 07/2002
7Disease Progression
11/2023 - 12/2016
7Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

533-nitrotyrosineIBA
10/2015 - 05/2002
50CytokinesIBA
10/2021 - 06/2002
41Peroxidase (Myeloperoxidase)IBA
11/2011 - 02/2003
39Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2010 - 02/2003
34CarrageenanIBA
01/2024 - 01/2002
25NF-kappa B (NF-kB)IBA
12/2014 - 01/2002
24Proteins (Proteins, Gene)FDA Link
11/2023 - 04/2006
24Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2014 - 01/2002
23EnzymesIBA
07/2020 - 01/2002
23DinitrobenzenesIBA
08/2011 - 07/2002
22LigandsIBA
01/2024 - 12/2003
22ZymosanIBA
09/2011 - 01/2002
21Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2024 - 01/2002
202,4-dinitrofluorobenzene sulfonic acidIBA
08/2011 - 07/2002
19Sulfonic AcidsIBA
08/2011 - 05/2002
18Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2019 - 12/2004
18Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2014 - 01/2002
17CeruletideIBA
03/2024 - 05/2002
16PPAR alphaIBA
01/2010 - 10/2004
15AntioxidantsIBA
12/2022 - 07/2003
15GlucocorticoidsIBA
02/2017 - 11/2004
14Reactive Oxygen Species (Oxygen Radicals)IBA
06/2023 - 07/2002
14Transcription Factors (Transcription Factor)IBA
10/2021 - 01/2002
14Interleukin-1beta (Interleukin 1 beta)IBA
04/2009 - 01/2002
13Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2019 - 01/2002
13Lipase (Acid Lipase)FDA Link
07/2012 - 05/2002
13AmylasesFDA Link
07/2012 - 05/2002
13Peroxynitrous Acid (Peroxynitrite)IBA
11/2010 - 11/2002
13DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2010 - 02/2005
12moringinIBA
05/2021 - 01/2016
12Neuroprotective AgentsIBA
01/2018 - 02/2011
11CannabinoidsIBA
01/2024 - 11/2014
11Collagen Type II (Type II Collagen)IBA
01/2024 - 10/2002
11Poly Adenosine Diphosphate RiboseIBA
07/2011 - 08/2002
11Bleomycin (Blenoxane)FDA LinkGeneric
07/2011 - 05/2005
10MicroRNAs (MicroRNA)IBA
02/2024 - 08/2019
10isothiocyanic acidIBA
03/2023 - 01/2015
10DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2002
10thioglucosidaseIBA
04/2019 - 08/2013
10P-SelectinIBA
10/2015 - 01/2002
9MelatoninIBA
05/2020 - 04/2005
9Interleukin-6 (Interleukin 6)IBA
01/2011 - 06/2002
8Macrophage Migration-Inhibitory FactorsIBA
03/2020 - 01/2018
8InterleukinsIBA
12/2019 - 08/2002
8Dexamethasone (Maxidex)FDA LinkGeneric
09/2015 - 06/2005
8AcidsIBA
04/2011 - 07/2002
8ProstaglandinsIBA
07/2009 - 05/2002
7Biomarkers (Surrogate Marker)IBA
02/2024 - 06/2005
7Glycogen Synthase (Synthase I)IBA
01/2024 - 05/2006
7LipopolysaccharidesIBA
03/2022 - 03/2003
7GlucosinolatesIBA
01/2022 - 01/2016
7CannabidiolIBA
06/2020 - 10/2015
7PolyphenolsIBA
04/2016 - 05/2005
7Fas Ligand Protein (Fas Ligand)IBA
11/2011 - 11/2006
7Nitric Oxide Synthase (NO Synthase)IBA
11/2011 - 05/2002
7Tyrosine (L-Tyrosine)FDA Link
05/2011 - 11/2005
7Superoxides (Superoxide)IBA
11/2010 - 07/2002
7Uridine Triphosphate (UTP)IBA
02/2010 - 02/2005
7salicylhydroxamic acid (SHAM)IBA
01/2010 - 01/2004
7Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2007 - 01/2002
6Monoclonal AntibodiesIBA
01/2024 - 10/2004

Therapy/Procedure

42Therapeutics
01/2023 - 01/2002
34Laminectomy
01/2015 - 02/2005
15Intraperitoneal Injections
07/2012 - 05/2002
7Ligation
05/2011 - 10/2005